DYNAMICS OF IMMUNOLOGICAL PARAMETERS IN PATIENTS WITH SLE DURING THE YEAR AFTER VACCINATION WITH 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE

被引：0
|
作者：
Koilubaeva, G. [1 ]
Tarasova, G. [2 ]
Belov, B. [2 ]
Bolotbekova, A. [1 ]
Turatbekova, A. [1 ]
Syunbai, G. K. [1 ]
机构：
[1] Rheumatol, 3 Togolok Moldo St, Bishkek, Kyrgyzstan
[2] Rheumatol, Kashirskoye Shosse 34, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Systemic lupus erythematosus;
D O I：
10.1136/annrheumdis-2023-eular.941
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1627
引用
收藏
页码：2047 / 2048
页数：2
相关论文
共 50 条
  • [1] SAFETY AND IMMUNOGENICITY OF 23-VALENT PNEUMOCOCCAL VACCINE IN SLE PATIENTS
    Tarasova, G.
    Belov, B.
    Bukhanova, D.
    Soloviev, S.
    Aseeva, E.
    Popkova, T.
    Cherkasova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1061 - 1061
  • [2] Analysis of Vaccination Rates of 23-Valent Pneumococcal Polysaccharide Vaccine in Hospitalized Patients with Diabetes
    Seagroves, Amy
    Reh, Christina S.
    Bischoff, Nathaniel
    Nally, Laura M.
    Singh, Jasjit
    DIABETES, 2017, 66 : A377 - A378
  • [3] Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine
    Yoon, Dongwon
    Jeon, Ha-Lim
    Kim, Ju Hwan
    Lee, Hyesung
    Shin, Ju-Young
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352597
  • [4] Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine
    Rose, MA
    Schubert, R
    Strnad, N
    Zielen, S
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (10) : 1216 - 1222
  • [5] 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia
    Tanimoto, Tetsuya
    Kusumi, Eiji
    Hosoda, Kazutaka
    Hamaki, Tamae
    Takahashi, Kenzo
    LANCET INFECTIOUS DISEASES, 2017, 17 (07): : 692 - 693
  • [6] 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia
    Suzuki, Motoi
    Dhoubhadel, Bhim Gopal
    Katoh, Shungo
    Ariyoshi, Koya
    Morimoto, Konosuke
    LANCET INFECTIOUS DISEASES, 2017, 17 (08): : 803 - 804
  • [7] TOLERABILITY, EFFICACY AND IMMUNOGENICITY OF 23-VALENT PNEUMOCOCCAL VACCINE IN SLE PATIENTS
    Tarasova, G. M.
    Belov, B. S.
    Sergeeva, M. S.
    Soloviev, S. K.
    Aseeva, E. A.
    Klukvina, N. G.
    Popkova, T. V.
    Alexandrova, E. N.
    Novikov, A. A.
    Cherkasova, M. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1226 - 1226
  • [8] IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH SPONDYLOARTHRITIS
    Muravyeva, N.
    Belov, B.
    Baranova, M.
    Cherkasova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 854 - 855
  • [9] Skin necrosis following 23-valent pneumococcal polysaccharide vaccination
    Thompson, Deborah L.
    Dores, Graca M.
    Ahluwalia, Jaspal
    Arya, Deepa P.
    Niu, Manette
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 450 - 450
  • [10] Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease
    Ohshima, Nobuharu
    Akeda, Yukihiro
    Nagai, Hideaki
    Oishi, Kazunori
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (09) : 2285 - 2291
12345